Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANEB-001 for reversal of THC intoxication in healthy occasional cannabis users
2021-000305-24Phase 2Completed
- Sponsor
- Anebulo Pharmaceuticals
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Cannabinoid intoxication comparing ANEB-001 + THC challenge with Placebo + THC challenge (2 arms). Primary endpoint: Visual Analogue Scale (VAS) "Feeling High". Started Feb 2021; status: completed.
02
Drugs
drinabant
03
Conditions
Cannabinoid intoxication
Beyond the preview
Go deeper on 2021-000305-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-000305-24.